Latest filings (excl ownership)
S-8
Registration of securities for employees
7 May 24
10-Q
2024 Q1
Quarterly report
7 May 24
8-K
Entry into a Material Definitive Agreement
6 May 24
8-K
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
6 May 24
424B5
Prospectus supplement for primary offering
3 May 24
8-K
Other Events
1 May 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
10-K
2023 FY
Annual report
19 Mar 24
8-K
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
19 Mar 24
8-K
Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell
23 Jan 24
8-K
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
7 Nov 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Other Events
6 Sep 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
20 Jun 23
EFFECT
Notice of effectiveness
9 May 23
10-Q
2023 Q1
Quarterly report
8 May 23
8-K
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
8 May 23
CORRESP
Correspondence with SEC
4 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
8-K
Other Events
24 Apr 23
8-K
Departure of Directors or Certain Officers
3 Apr 23
UPLOAD
Letter from SEC
31 Mar 23
8-K
Termination of a Material Definitive Agreement
29 Mar 23
S-3
Shelf registration
28 Mar 23
S-8
Registration of securities for employees
28 Mar 23
10-K
2021 FY
Annual report
28 Mar 23
8-K
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
28 Mar 23
8-K
Regulation FD Disclosure
10 Mar 23
8-K/A
Submission of Matters to a Vote of Security Holders
3 Nov 22
8-K
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
3 Nov 22
10-Q
2022 Q3
Quarterly report
3 Nov 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
28 Oct 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
8-K
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
8 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
17 Jun 22
S-8
Registration of securities for employees
5 May 22
Latest ownership filings
4
RICHARD A MD MILLER
14 May 24
SC 13G/A
SAMLYN CAPITAL, LLC
13 May 24
SC 13G
Point72 Asset Management, L.P.
9 May 24
4
Peter A. Thompson
8 May 24
4
Change in insider ownership
8 May 24
SC 13D/A
ORBIMED ADVISORS LLC
8 May 24
4
William Benton Jones
7 May 24
4
RICHARD A MD MILLER
7 May 24
4
Jeffrey Arcara
1 Mar 24
SC 13G
SAMLYN CAPITAL, LLC
14 Feb 24
SC 13G/A
MILLER RICHARD A MD
13 Feb 24
3
Jeffrey Arcara
8 Feb 24
4
RICHARD A MD MILLER
8 Dec 23
4
LEIV LEA
8 Dec 23
4
William Benton Jones
8 Dec 23
4
Edith P. Mitchell
8 Dec 23
4
Linda Grais
8 Dec 23
4
IAN T CLARK
8 Dec 23
4
Scott W Morrison
8 Dec 23
4
Terry P Gould
8 Dec 23
4
Peter A. Thompson
8 Dec 23
4
Peter A. Thompson
20 Jun 23
4
Terry P Gould
20 Jun 23
4
IAN T CLARK
20 Jun 23
4
Scott W Morrison
20 Jun 23
4
Linda Grais
20 Jun 23
4
Edith P. Mitchell
20 Jun 23
4
Linda Grais
16 May 23
4
RICHARD A MD MILLER
3 Apr 23
SC 13G/A
TANG CAPITAL PARTNERS LP
14 Feb 23
SC 13G
CHI Advisors LLC
13 Feb 23
SC 13G/A
MILLER RICHARD A MD
10 Feb 23
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
30 Jan 23
4
William Benton Jones
20 Dec 22
4
LEIV LEA
15 Dec 22
4
RICHARD A MD MILLER
15 Dec 22
4
RICHARD A MD MILLER
28 Sep 22
4
RICHARD A MD MILLER
20 Sep 22
4
LEIV LEA
15 Aug 22
4
Peter A. Thompson
15 Aug 22